Shun'e J. Yang
Ueruemqi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.
Journal: Therapeutic advances in medical oncology
Published: December 21, 2021
Increased Risk of Lymphoma in Men or the Elderly Infected with Tuberculosis.
Journal: Mediterranean journal of hematology and infectious diseases
Published: May 23, 2021
Cancer risk in tuberculosis patients in a high endemic area.
Journal: BMC cancer
Published: October 31, 2020
Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial.
Journal: Advances in therapy
Published: October 23, 2020
MicroRNA-103a-3p potentiates chemoresistance to cisplatin in non-small cell lung carcinoma by targeting neurofibromatosis 1.
Journal: Experimental and therapeutic medicine
Published: July 21, 2018
MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphoma.
Journal: Experimental and therapeutic medicine
Published: October 30, 2017
Relationship between the acylation-stimulating protein gene and coronary heart disease in the Xinjiang Uygur and Han populations of China.
Journal: Genetics and molecular research : GMR
Published: May 01, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026